Skip to content

CategoryUncategorized

New Publication Supports Clinical Effectiveness of Centinel Spine’s Stand-Alone STALIF® M Integrated Interbody™ Portfolio

Study conducted by the Texas Back Institute (TBI), Plano, TX and published in the International Journal of Spine Surgery The retrospective study supports utilizing STALIF M portfolio implants as a … Continue Reading New Publication Supports Clinical Effectiveness of Centinel Spine’s Stand-Alone STALIF® M Integrated Interbody™ Portfolio

Centinel Spine in the News: ‘There is going to be a fundamental shift from fusion to motion preservation,’ says Centinel Spine CEO

Source: Becker’s Spine Steve Murray joined privately held spinal tech company Centinel Spine as its CEO on March 16, 2020, just days before the COVID-19 pandemic shut down the U.S.  … Continue Reading Centinel Spine in the News: ‘There is going to be a fundamental shift from fusion to motion preservation,’ says Centinel Spine CEO

Centinel Spine Wins Third Consecutive Spine Technology Award for prodisc® Cervical Portfolio & Match-the-Disc Platform

Centinel Spine wins Best New Technology Award for its prodisc® Cervical Portfolio & Match-the-Disc Platform prodisc portfolio includes four total disc replacement devices approved by the U.S. Food and Drug … Continue Reading <strong>Centinel Spine Wins Third Consecutive Spine Technology Award for </strong>pro<strong>disc</strong>®<strong> Cervical Portfolio & Match-the-Disc Platform</strong>

Study Featured at NASS 2022 Demonstrates Long-Term Effectiveness of Centinel Spine’s prodisc® L Total Disc Replacement

prodisc L is the only total disc replacement system in the U.S. approved for two-level use in the lumbar spine. Centinel Spine is the only company with FDA-approved cervical and … Continue Reading <strong>Study Featured at NASS 2022 Demonstrates Long-Term Effectiveness of Centinel Spine’s </strong>pro<strong>disc® L Total Disc Replacement</strong>

Centinel Spine® Continues Launch of New Portfolio of prodisc® Cervical Total Disc Replacement Devices & Features at NASS 2022

Centinel Spine is the first-and-only company with a portfolio that allows matching the disc to patient anatomy. Centinel Spine now has four FDA-approved cervical total disc replacement devices for 1-level … Continue Reading Centinel Spine® Continues Launch of New Portfolio of prodisc® Cervical Total Disc Replacement Devices & Features at NASS 2022

Centinel Spine® Announces First Commercial Use of the prodisc® C Vivo Cervical Total Disc Replacement System in the Western U.S.

Centinel Spine continues to advance the release of the recently-approved prodisc® C Vivo system. Centinel Spine now has four FDA-approved cervical total disc replacement devices for 1-level indications, offering the broadest … Continue Reading Centinel Spine® Announces First Commercial Use of the prodisc® C Vivo Cervical Total Disc Replacement System in the Western U.S.

Centinel Spine® Announces First Commercial Use of prodisc® Cervical Total Disc Replacement Portfolio that Allows the Disc to be Matched to Patient Anatomy

Centinel Spine now has four FDA-approved cervical total disc replacement (TDR) devices for 1-level indications, offering the broadest spectrum of solutions to address surgeon preference and individual patient anatomy. Centinel … Continue Reading <strong>Centinel Spine® Announces First Commercial Use of </strong>pro<strong>disc® Cervical Total Disc Replacement Portfolio that Allows the Disc to be Matched to Patient Anatomy</strong>

Centinel Spine® Expands Its Comprehensive Cervical Solutions Portfolio With Full Commercial Launch of FORTOS-C™ Anterior Cervical Plating System

The FORTOS-C™ cervical fusion plate is one of the lowest profile designs on the market and incorporates an open architecture, pre-contoured lordosis, and simple one-step blocking mechanism. The plate complements … Continue Reading Centinel Spine® Expands Its Comprehensive Cervical Solutions Portfolio With Full Commercial Launch of FORTOS-C™ Anterior Cervical Plating System

Centinel Spine in the News: Clinical Trial to Test Replacement Devices for Two-Level Symptomatic Cervical Disc Disease

Source: Hospital For Special Surgery via PR Newswire A multicenter, prospective, randomized controlled trial is designed to assess the effectiveness of three different disc replacement devices used for two-level symptomatic … Continue Reading Centinel Spine in the News: Clinical Trial to Test Replacement Devices for Two-Level Symptomatic Cervical Disc Disease

Centinel Spine in the News: Centinel Spine Clinical Study for Total Disc Replacement for 2-Level Symptomatic Cervical Disc Disease

Source: Texas Spine Care Center via PR Newswire Texas Spine Care Center announced today their 10th patient enrolled in the Centinel Spine, LLC, Multicenter, Prospective, Randomized Controlled Trial Comparing the … Continue Reading Centinel Spine in the News: Centinel Spine Clinical Study for Total Disc Replacement for 2-Level Symptomatic Cervical Disc Disease

Major Commercial Third Party Payer in Utah & Idaho Significantly Expands Patient Access to Centinel Spine’s prodisc® L for One- and Two-level Lumbar Total Disc Replacement

A major commercial third party payer in Utah and Idaho, representing 837,000 covered lives, has established positive coverage for both one- and two-level lumbar total disc replacement (TDR) procedures, which … Continue Reading Major Commercial Third Party Payer in Utah & Idaho Significantly Expands Patient Access to Centinel Spine’s prodisc® L for One- and Two-level Lumbar Total Disc Replacement